1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
2
|
Chen W, Zheng R, Zhang S, Zeng H, Xia C,
Zuo T, Yang Z, Zou X and He J: Cancer incidence and mortality in
China, 2013. Cancer Lett. 401:63–71. 2017.PubMed/NCBI View Article : Google Scholar
|
3
|
Liang H, Fan JH and Qiao YL: Epidemiology,
etiology, and prevention of esophageal squamous cell carcinoma in
China. Cancer Biol Med. 14:33–41. 2017.PubMed/NCBI View Article : Google Scholar
|
4
|
Sanchez CA, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018.PubMed/NCBI View Article : Google Scholar
|
5
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Chi Y, Wang D, Wang J, Yu W and Yang J:
Long non-coding RNA in the pathogenesis of cancers. Cells.
8(1015)2019.PubMed/NCBI View Article : Google Scholar
|
7
|
Bunch H: Gene regulation of mammalian long
non-coding RNA. Mol Genet Genomics. 293:1–15. 2018.PubMed/NCBI View Article : Google Scholar
|
8
|
Palmieri G, Paliogiannis P, Sini MC, Manca
A, Palomba G, Doneddu V, Tanda F, Pascale MR and Cossu A: Long
non-coding RNA CASC2 in human cancer. Crit Rev Oncol Hematol.
111:31–38. 2017.PubMed/NCBI View Article : Google Scholar
|
9
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010.PubMed/NCBI View Article : Google Scholar
|
10
|
Wahlestedt C: Targeting long non-coding
RNA to therapeutically upregulate gene expression. Nat Rev Drug
Discov. 12:433–446. 2013.PubMed/NCBI View
Article : Google Scholar
|
11
|
Chen B, Li Y, He Y, Xue C and Xu F: The
emerging roles of long non-coding RNA in gallbladder cancer
tumorigenesis. Cancer Biomark. 22:359–366. 2018.PubMed/NCBI View Article : Google Scholar
|
12
|
Xie H, Ma B, Gao Q, Zhan H, Liu Y, Chen Z,
Ye S, Li J, Yao L and Huang W: Long non-coding RNA CRNDE in cancer
prognosis: Review and meta-analysis. Clin Chim Acta. 485:262–271.
2018.PubMed/NCBI View Article : Google Scholar
|
13
|
Ma J, Xiao Y, Tian B, Chen S, Zhang B, Wu
J, Wu Z, Li X, Tang J, Yang D, et al: Genome-wide analyses of long
non-coding RNA expression profiles and functional network analysis
in esophageal squamous cell carcinoma. Sci Rep.
9(9162)2019.PubMed/NCBI View Article : Google Scholar
|
14
|
Zhang Y, Li R, Ding X, Zhang K and Qin W:
Upregulation of long non-coding RNA SNHG6 promote esophageal
squamous cell carcinoma cell malignancy and its diagnostic value.
Am J Transl Res. 11:1084–1091. 2019.PubMed/NCBI
|
15
|
Razavi M and Ghorbian S: Up-regulation of
long non-coding RNA-PCAT-1 promotes invasion and metastasis in
esophageal squamous cell carcinoma. EXCLI J. 18:422–428.
2019.PubMed/NCBI View Article : Google Scholar
|
16
|
Zong MZ, Feng WT, Du N, Yu XJ and Yu WY:
Upregulation of long noncoding RNA LEF1-AS1 predicts a poor
prognosis in patients with esophageal squamous cell carcinoma. Eur
Rev Med Pharmacol Sci. 23:7929–7934. 2019.PubMed/NCBI View Article : Google Scholar
|
17
|
Ma J, Xiao Y, Tian B, Chen S, Zhang B, Wu
J, Wu Z, Li X, Tang J, Yang D, et al: Long noncoding RNA
lnc-ABCA12-3 promotes cell migration, invasion, and proliferation
by regulating fibronectin 1 in esophageal squamous cell carcinoma.
J Cell Biochem. 121:1374–1387. 2020.PubMed/NCBI View Article : Google Scholar
|
18
|
Zhu D, Yu Y, Qi Y, Wu K, Liu D, Yang Y,
Zhang C and Zhao S: Long non-coding RNA CASC2 enhances the
antitumor activity of cisplatin through suppressing the Akt pathway
by inhibition of miR-181a in esophageal squamous cell carcinoma
cells. Front Oncol. 9(350)2019.PubMed/NCBI View Article : Google Scholar
|
19
|
Hou H, Meng Z, Zhao X, Ding G, Sun M, Wang
W and Wang Y: Survival of esophageal cancer in China: A pooled
analysis on hospital-based studies from 2000 to 2018. Front Oncol.
9(548)2019.PubMed/NCBI View Article : Google Scholar
|
20
|
Yang L, Xu L, Wang Q, Wang M and An G:
Dysregulation of long non-coding RNA profiles in human colorectal
cancer and its association with overall survival. Oncol Lett.
12:4068–4074. 2016.PubMed/NCBI View Article : Google Scholar
|
21
|
Kawasaki Y, Komiya M, Matsumura K, Negishi
L, Suda S, Okuno M, Yokota N, Osada T, Nagashima T, Hiyoshi M, et
al: MYU, a target lncRNA for Wnt/c-Myc signaling, mediates
induction of CDK6 to promote cell cycle progression. Cell Rep.
16:2554–2564. 2016.PubMed/NCBI View Article : Google Scholar
|
22
|
Wang J, Yang X, Li R, Wang L, Gu Y, Zhao
Y, Huang KH, Cheng T, Yuan Y and Gao S: Long non-coding RNA MYU
promotes prostate cancer proliferation by mediating the
miR-184/c-Myc axis. Oncol Rep. 40:2814–2825. 2018.PubMed/NCBI View Article : Google Scholar
|
23
|
Tan J and Yang L: Long noncoding RNA
VPS9D1-AS1 overexpression predicts a poor prognosis in non-small
cell lung cancer. Biomed Pharmacother. 106:1600–1606.
2018.PubMed/NCBI View Article : Google Scholar
|
24
|
Wang X, Chen Q, Wang X, Li W, Yu G, Zhu Z
and Zhang W: ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis
and progression of prostate cancer by sponging miR-4739 to
upregulate MEF2D. Biomed Pharmacother. 122(109557)2020.PubMed/NCBI View Article : Google Scholar
|